Get started
Work

Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study)

Year: 2019
Type: article
DOI: 10.1016/j.amjcard.2019.03.017
Authors: Alvaro Alonso, Bing Yu, Yan V. Sun, Lin Y. Chen, Laura R. Loehr, Wesley T. O'Neal, Elsayed Z. Soliman, Eric Boerwinkle
Institutions: Emory University, The University of Texas Health Science Center at Houston, University of Minnesota, University of North Carolina at Chapel Hill, Wake Forest University Health Sciences, Wake Forest University, Baylor College of Medicine
Language: English
Field: Medicine
Open Access status: green
Funders: U.S. Department of Health and Human Services, American Heart Association, National Institute for Health and Care Research, Department of Health and Aged Care, Australian Government, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute
Awards: G1114307781, The Application of Genomics and Metabolomics on Coronary Heart Disease Risk Prediction, Metabolic Signatures Underlying Cardiac Function for Heart Failure in Multi-Ethnic Populations, G1626362228, G1788514665, GWA for Gene-Environment Interaction Effects Influencing CHD, G3973572274, G4747441672, G4790942633, G5352314984, Atrial fibrillation: epidemiology, prevention, and outcomes, G5770678025, G5928944960, G6060132884, G6739173425, G6787570788, G6837735701, G7155745631, G7535686976, Trans-omics Analysis to Unravel Molecular Underpinnings of Heart, Lung and Blood Disease Risk Factors, G8738262636
OpenAlex ID: W2949402948
FWCI: 3.352
Cites: 47
Cited by: 51
Related to: 10